Suppliers with verified business licenses
| Drug Name | Human Immunoglobulin (pH4) for Intravenous Injection | |
| Ingredients | Ingredients: | More than 95% of protein in this product is immunoglobulin |
| Excipients: | Maltose | |
| Appearance | This product shall be clear, colorless or light yellow liquid, opalescence may occur but without turbidity. | |
| Indications | 1. Primary immunoglobulin deficiency diseases, such as X-linked agammaglobulinemia, common variant immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency diseases, such as severe infection, neonatal septicemia, etc. 3. Autoimmune diseases, such as primary thrombocytopenic purpura and Kawasaki disease. |
|
| Specification | 200ml:10g; 100ml:5g; 50ml:2.5g; 20ml:1g; 10ml:0.5g | |
| Storage | Store and transport at 2~8ºC, protected from light. | |
| Package | Neutral Borosilicate Glass Molded Injection Bottle, 1 bottle/box | |
| Validity Period | 36 months | |
| Executive Standard | "Chinese Pharmacopoeia", 2020 Edition | |
Suppliers with verified business licenses
){kind=link}
){kind=link}